dc.contributor.author | Bloniecki, Victor | |
dc.contributor.author | Ulfvarson, J. | |
dc.contributor.author | Javanshiri, K. | |
dc.contributor.author | Hagman, G. | |
dc.contributor.author | Freund-Levi, Y. | |
dc.contributor.author | Nordströmg, A. | |
dc.date.accessioned | 2023-08-25T11:25:55Z | |
dc.date.available | 2023-08-25T11:25:55Z | |
dc.date.issued | 2023-01-23 | |
dc.description.abstract | BACKGROUND: There is a need for the development of
accurate, accessible and efficient screening instruments, focused
on early-stage detection of neurocognitive disorders. The Geras
Solutions cognitive test (GSCT) has showed potential as a digital
screening tool for cognitive impairment but normative data are
needed.<p>
<p>OBJECTIVE: The aim of this study was to obtain normative data
for the GSCT in cognitively healthy patients, investigate the
effects of gender and education on test scores as well as examine
test-retest reliability.
<p>METHODS: The population in this study consisted of 144
cognitively healthy subjects (MMSE>26) all at the age of 70 who
were earlier included in the Healthy Aging Initiative Study
conducted in Umeå, Sweden. All patients conducted the GSCT
and a subset of patients (n=32) completed the test twice in order
to establish test-retest reliability.
<p>RESULTS: The mean GSCT score was 46.0 (±4.5) points. High
level of education (>12 years) was associated with a high GSCT
score (p = 0.02) while gender was not associated with GSCT
outcomes (p = 0.5). GSCT displayed a high correlation between
test and retest (r(30) = 0.8, p <0.01).
<p>CONCLUSION: This study provides valuable information
regarding normative test-scores on the GSCT for cognitively
healthy individuals and indicates education level as the
most important predictor of test outcome. Additionally, the
GSCT appears to display a good test-retest reliability further
strengthening the validity of the test. | en_US |
dc.identifier.citation | Bloniecki, Ulfvarson, Javanshiri, Hagman, Freund-Levi, Nordströmg. The Geras Solutions Cognitive Test for Assessing Cognitive Impairment: Normative Data from a Population-Based Cohort. Journal of Prevention of Alzheimer's Disease (JPAD). 2023;10:207-211 | en_US |
dc.identifier.cristinID | FRIDAID 2141872 | |
dc.identifier.doi | 10.14283/jpad.2023.9 | |
dc.identifier.issn | 2274-5807 | |
dc.identifier.issn | 2426-0266 | |
dc.identifier.uri | https://hdl.handle.net/10037/30436 | |
dc.language.iso | eng | en_US |
dc.publisher | Springer Nature | en_US |
dc.relation.journal | Journal of Prevention of Alzheimer's Disease (JPAD) | |
dc.rights.accessRights | openAccess | en_US |
dc.rights.holder | Copyright 2023 The Author(s) | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | en_US |
dc.rights | Attribution 4.0 International (CC BY 4.0) | en_US |
dc.title | The Geras Solutions Cognitive Test for Assessing Cognitive Impairment: Normative Data from a Population-Based Cohort | en_US |
dc.type.version | publishedVersion | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |